Certara (CERT) to Release Quarterly Earnings on Thursday

Certara (NASDAQ:CERT) is projected to announce its earnings results after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of $0.12 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Certara Price Performance

Certara stock opened at $12.33 on Thursday. The firm has a market capitalization of $1.98 billion, a P/E ratio of -61.65, a PEG ratio of 9.29 and a beta of 1.57. Certara has a one year low of $9.41 and a one year high of $19.87. The business has a fifty day moving average price of $12.39 and a 200-day moving average price of $11.63. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86.

Wall Street Analyst Weigh In

CERT has been the subject of a number of research reports. Robert W. Baird cut their price objective on shares of Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a research note on Tuesday, November 5th. Barclays decreased their price objective on shares of Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a report on Thursday, November 7th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $15.30.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.